HONG KONG, March 14, 2025 /PRNewswire/ -- Teva Hong Kong ('Teva'), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ('KLN'). Leveraging Kerry Pharma's extensive logistics (fourth-party logistics, 4PL) distribution capabilities, this collaboration aims to enhance Teva's pharmaceutical distribution system in Hong Kong, Macau, and the Greater Bay Area, ensuring a stable supply of high-quality medical products. This initiative not only strengthens Teva's presence in Hong Kong, Macau, and the Greater Bay Area, enhancing product distribution system resilience and driving quality and efficiency improvements in the regional pharmaceutical industry, but also marks a crucial step in building an efficient, transparent, and sustainable pharmaceutical supply model that prioritizes patient care.